[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

NCT06502691 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma

Interventions

OTHER: Best Practice
PROCEDURE: Biopsy of Breast
PROCEDURE: Computed Tomography
OTHER: Electronic Health Record Review
OTHER: Fludeoxyglucose F-18
RADIATION: Fluorine F 18 Fluorthanatrace
DRUG: Immune Checkpoint Inhibitor
DRUG: Poly (ADP-Ribose) Polymerase Inhibitor
PROCEDURE: Positron Emission Tomography
PROCEDURE: Positron Emission Tomography

Sponsor

University of Washington

Collaborators

[object Object]